Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-25 @ 3:20 AM
NCT ID:
NCT06060405
Brief Title:
Durvalumab and Oleclumab in Resectable PDAC
Official Title:
Durvalumab and Oleclumab in Resectable PDAC: A Window of Opportunity Study (DORA Trial)
Acronym:
DORA
Study:
NCT06060405
Protocol Section:
NCT06060405